Literature DB >> 4732107

Correction of the enzymic defect in cultured fibroblasts from patients with Fabry's disease: treatment with purified alpha-galactosidase from ficin.

G Dawson, R Matalon, Y T Li.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4732107     DOI： 10.1203/00006450-197308000-00002

Source DB:  PubMed          Journal:  Pediatr Res        ISSN： 0031-3998            Impact factor:   3.756


× No keyword cloud information.
  5 in total

1.  The correction of Hunter fibroblasts by exogenous iduronate sulfate sulfatase: biochemical and ultrastructural studies.

Authors:  R Eliahu; E Sekeles; R Cohen; G Bach
Journal:  Am J Hum Genet       Date:  1981-07       Impact factor: 11.025

2.  Proceedings of the Annual Meeting of the European Foundation for Bone Marrow Transplantation, Sils Maria (Engadine), Switzerland, April 13-16, 1980.

Authors: 
Journal:  Blut       Date:  1980-09

3.  The use of quantiatative cytochemical analyses in rapid prenatal detection and somatic cell genetic studies of metabolic diseases.

Authors:  H Galjaard; A Hoogeveen; W Keijzer; E De Wit-Verbeek; C Vlek-Noot
Journal:  Histochem J       Date:  1974-09

4.  Endocytosis of lysosomal alpha-galactosidase A by cultured fibroblasts from patients with Fabry disease.

Authors:  J S Mayes; E L Cray; V A Dell; J B Scheerer; R N Sifers
Journal:  Am J Hum Genet       Date:  1982-07       Impact factor: 11.025

5.  Loss of electron-dense lamellar material from Fabry's disease fibroblasts after enzyme replacement.

Authors:  R N Sifers; J S Mayes; R E Nordquist
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.